Istituto Superiore di Sanità, Center for Gender-Specific Medicine, Rome, Italy.
Department of Public Health and Infectious Diseases, Istituto Pasteur Italia-Fondazione Cenci-Bolognetti, Sapienza University of Rome, Italy.
Oxid Med Cell Longev. 2019 Feb 13;2019:6452390. doi: 10.1155/2019/6452390. eCollection 2019.
Hepatitis C virus (HCV) is a blood-borne pathogen causing acute and chronic hepatitis. A significant number of people chronically infected with HCV develop cirrhosis and/or liver cancer. The pathophysiologic mechanisms of hepatocyte damage associated with chronic HCV infection are not fully understood yet, mainly due to the lack of an system able to recapitulate the stages of infection . Several studies underline that HCV virus replication depends on redox-sensitive cellular pathways; in addition, it is known that virus itself induces alterations of the cellular redox state. However, the exact interplay between HCV replication and oxidative stress has not been elucidated. In particular, the role of reduced glutathione (GSH) in HCV replication and infection is still not clear. We set up an system, based on low m.o.i. of Huh7.5 cell line with a HCV infectious clone (J6/JFH1), that reproduced the acute and persistent phases of HCV infection up to 76 days of culture. We demonstrated that the acute phase of HCV infection is characterized by the elevated levels of reactive oxygen species (ROS) associated in part with an increase of NADPH-oxidase transcripts and activity and a depletion of GSH accompanied by high rates of viral replication and apoptotic cell death. Conversely, the chronic phase is characterized by a reestablishment of reduced environment due to a decreased ROS production and increased GSH content in infected cells that might concur to the establishment of viral persistence. Treatment with the prooxidant auranofin of the persistently infected cultures induced the increase of viral RNA titer, suggesting that a prooxidant state could favor the reactivation of HCV viral replication that in turn caused cell damage and death. Our results suggest that targeting the redox-sensitive host-cells pathways essential for viral replication and/or persistence may represent a promising option for contrasting HCV infection.
丙型肝炎病毒 (HCV) 是一种血液传播病原体,可引起急性和慢性肝炎。大量慢性 HCV 感染者会发展为肝硬化和/或肝癌。与慢性 HCV 感染相关的肝细胞损伤的病理生理机制尚未完全阐明,主要是因为缺乏能够重现感染阶段的系统。多项研究强调 HCV 病毒复制依赖于氧化还原敏感的细胞途径;此外,已知病毒本身会诱导细胞氧化还原状态的改变。然而,HCV 复制和氧化应激之间的确切相互作用尚未阐明。特别是,还原型谷胱甘肽 (GSH) 在 HCV 复制和感染中的作用仍不清楚。我们建立了一个基于低感染复数(m.o.i.)的 Huh7.5 细胞系 HCV 感染性克隆(J6/JFH1)的系统,该系统可复制 HCV 感染的急性和持续阶段,培养时间长达 76 天。我们证明 HCV 感染的急性期的特征是活性氧 (ROS) 水平升高,部分原因是 NADPH 氧化酶转录本和活性增加以及 GSH 耗竭,同时伴随着高病毒复制率和细胞凋亡。相反,慢性期的特征是由于感染细胞中 ROS 产生减少和 GSH 含量增加而恢复还原环境,这可能有助于病毒持续存在。用促氧化剂 auranofin 处理持续感染的培养物会诱导病毒 RNA 滴度增加,这表明促氧化剂状态可能有利于 HCV 病毒复制的重新激活,而这反过来又会导致细胞损伤和死亡。我们的结果表明,针对病毒复制和/或持续所必需的氧化还原敏感的宿主细胞途径可能是对抗 HCV 感染的有前途的选择。